Mazor Robotics Has a 'Very Robust' Pipeline: CEO

The video discusses the Renaissance spine robotic system, which precisely positions surgical tools for spine and brain surgeries. The system has expanded globally, with significant sales in the US and other countries. Over 9,000 surgeries have been performed using this system. The company has experienced revenue growth, although the first half of the year was weak. The second half showed stronger performance, and the company expects significant growth, supported by a robust market pipeline.

What was the revenue growth trend discussed in the previous year?

What is the expected growth in the second half of the year based on the discussion?